Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bairui Keli for pediatric acute upper respiratory tract infection (wind-heat pattern)
CTR20241463Phase 3Completed
- Sponsor
- Jiuhua Huayuan Pharmaceutical
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Bairui granules in upper respiratory infection (URI), sponsored by Jiuhua Huayuan Pharmaceutical. Started Apr 2024; status: completed.
02
Drugs
Bairui granules
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20241463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241463.